Humana (HUM)
NYSEHealth CareHealthcare PlansSnapshot 2026-07-08
$396.58+0.50%
Close 2026-07-08 · 1-day change
Reading HUM? This analysis is rebuilt every market day. Get it tracked free. No credit card.
Track HUM free→NYSEHealth CareHealthcare PlansSnapshot 2026-07-08
Reading HUM? This analysis is rebuilt every market day. Get it tracked free. No credit card.
Track HUM free→Warn: Management is running behind on a stated commitment.
Humana keeps its EPS guidance at $9.00 for 2026. It won a big Illinois Medicaid contract that should boost revenue and margins. The company also announced a share buyback program, showing strong capital allocation. Recent earnings beats support steady profit growth.
EPS guidance is soft and behind targets. Net income declined sharply in late 2025. Management is volatile, and capital obligations have increased. These risks could pressure margins and growth.
The price is about 21% above our fair value near $322. Analysts expect 16% revenue growth. Our fair value is 24% above the Street median, reflecting confidence in Humana's growth and margin outlook.
Breaks if: Buyback program is halted or materially reduced
Humana announced a share buyback program as part of its capital allocation strategy.
Standing thesis, reviewed periodically — not a price target or advice.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
Breaks if: EPS guidance falls below $9.00 for FY 2026
Humana aims to maintain its EPS guidance of at least $9.00 for the fiscal year 2026.
Stated in 4 of last 4 quarters. Humana has consistently maintained its EPS guidance of at least $9.00 for FY 2026. Despite a net income decline to -$274M in 2025-Q4, the company continues to reaffirm this guidance, indicating persistent focus but limited substantive delivery so far.
“The Company intends to reaffirm its guidance of at least $9.00 in adjusted earnings per common share for FY 2026.”
“Humana introduces its GAAP EPS guidance for FY 2026 of 'at least $8.89', or 'at least $9.00' on an Adjusted basis.”
“The Company intends to reaffirm its guidance of at least $9.00 in adjusted earnings per common share for FY 2026.”
“Affirming its Adjusted EPS guidance of 'at least $9.00'.”
Breaks if: Revenue growth falls below 15% YoY in FY26